Add Company
Join Now

NeRRe Therapeutics Revenue and Competitors

License our Company Data API

Stevenage,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NeRRe Therapeutics's estimated annual revenue is currently $2M per year.(i)
  • NeRRe Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • NeRRe Therapeutics has 13 Employees.(i)
  • NeRRe Therapeutics grew their employee count by 0% last year.

NeRRe Therapeutics's People

NameTitleEmail/Phone
1
VP Clinical OperationsReveal Email/Phone
2
SVP, CMC - NeRRe TherapeuticsReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Co-Founder & Chief Scientific OfficerReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Office Manager/Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is NeRRe Therapeutics?

NeRRe Therapeutics is a clinical stage company progressing a unique portfolio of three neurokinin-1 antagonists (NK-1RAs) for the treatment of common, chronic and debilitating conditions, caused by neuronal hypersensitivity related to NK-1 receptor system dysfunction. It's lead compound orvepitant is in a multinational Phase 2b trial in patients suffering from chronic refractory cough, a neuronal hypersensitivity condition for which there are no approved treatments.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M160%N/A
#2
$2.4M24N/AN/A
#3
$3.7M249%$3M
#4
$2M2663%N/A
#5
$6.7M3111%N/A